Loading company…
Ruige Pharmaceutical researches and develops drugs for cancer, autoimmune, and metabolic diseases.
Established in 2018 and based in Shanghai, Ruige Pharmaceutical researches and develops drugs for cancer, autoimmune, and metabolic diseases. Its CARD platform combines structural biology, computational and medicinal chemistry, and biology to support drug research and development.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in